Adam Lambert
Papers
1
Total Citations
18
H-Index
1
About
Dr. Adam Lambert is pioneering the field of molecularly targeted intraoperative imaging for prostate cancer surgery. His research centers on the development and clinical translation of novel optical imaging agents, with a particular focus on prostate-specific membrane antigen (PSMA)-targeted probes. Dr. Lambert’s landmark contribution is the first-in-human study of the PSMA Minibody IR800-IAB2M, a humanized antibody fragment conjugated to a near-infrared fluorophore. This work, published in 2024 and already cited 18 times, demonstrates the feasibility of real-time, molecularly guided fluorescence guidance during robot-assisted laparoscopic radical prostatectomy. By enabling surgeons to visualize microscopic tumor deposits that are invisible to the naked eye, his research directly addresses the critical challenge of positive surgical margins. Dr. Lambert’s achievements represent a significant leap toward precision oncologic surgery, potentially reducing recurrence rates and improving patient outcomes. His ongoing work continues to push the boundaries of how molecular imaging can be integrated into the operating room, establishing him as a leading voice in the emerging field of image-guided cancer surgery.
Research Focus
Key Achievements
Top Papers
- 1